Filing Details
- Accession Number:
- 0001209191-10-053186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-04 16:41:37
- Reporting Period:
- 2010-11-02
- Filing Date:
- 2010-11-04
- Accepted Time:
- 2010-11-04 16:41:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1421616 | Graham Burton | C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-11-02 | 10,000 | $63.28 | 51,981 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-11-02 | 1,200 | $7.28 | 53,181 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-02 | 148 | $62.95 | 53,033 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-11-02 | 1,200 | $0.00 | 1,200 | $7.78 |
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2010-11-02 | 148 | $0.00 | 148 | $62.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 147,408 | 2013-07-03 | No | 4 | M | Direct | |
| 148 | 2011-05-02 | 2013-07-03 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,291 | Indirect | 401(k) Plan |
Footnotes
- This transaction reflects the exercise of options resulting in the acquisition of 1,052 shares. No shares were sold in the open market.
- The option was fully exercisable.
- The option was issued pursuant to the Company's 2008 Stock Incentive Plan.
Billionaire Hedge Funds
